Lin Benyao相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients

DNA修复基因的种系突变与BRCA1/2阴性乳腺癌患者的预后不良相关

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.14175

Fan, Zhenhua; Hu, Li; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Xu, Ye; Xie, Yuntao

发表日期：2019

文献求助收藏

Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer

新辅助化疗后残留病灶中TP53和PIK3CA的共突变与乳腺癌患者预后不良相关。

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-019-02873-8

Chen, Xinyi; Guo, Yonghai; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Xu, Ye; Xie, Yuntao

发表日期：2019

文献求助收藏

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers

BRCA1/2 mRNA表达对BRCA阴性乳腺癌新辅助化疗疗效的预测价值

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.13426

Xu, Ye; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Xie, Yuntao

发表日期：2018

文献求助收藏

Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.

RECQL低表达与中国乳腺癌患者预后不良相关

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-018-4585-1

Xu Huiying, Xu Ye, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yuntao

发表日期：2018

文献求助收藏

Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer

HER2种系突变A270S与原发性乳腺癌患者预后的关系

期刊:Cancer Biomarkers

影响因子:1.9

doi:10.3233/CBM-170466

Si, Pilei; Xu, Ye; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Xie, Yuntao

发表日期：2018

文献求助收藏

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer

HER2 Pro1170Ala 多态性与 HER2 阴性乳腺癌患者的生存率降低相关

期刊:Oncology Letters

影响因子:2.2

doi:10.3892/ol.2017.5866

Si, Pilei; Xu, Ye; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Xie, Yuntao

发表日期：2017

文献求助收藏

Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer

HER2状态与乳腺癌新辅助蒽环类药物序贯紫杉醇加卡铂化疗（不含曲妥珠单抗）疗效之间的关联

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.3978/j.issn.1000-9604.2015.12.03

Yao, Lu; Zhang, Juan; Liu, Yiqiang; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Xie, Yuntao

发表日期：2015

文献求助收藏

Breast-conserving therapy and modified radical mastectomy for primary breast carcinoma: a matched comparative study

保乳治疗与改良根治性乳房切除术治疗原发性乳腺癌：一项匹配比较研究

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.3978/j.issn.1000-9604.2015.11.02

Wang, Lize; Ouyang, Tao; Wang, Tianfeng; Xie, Yuntao; Fan, Zhaoqing; Lin, Benyao; Li, Jinfeng

发表日期：2015

文献求助收藏

Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer

治疗前生物标志物在预测激素受体阳性绝经后乳腺癌新辅助内分泌治疗反应中的价值

期刊:Chinese Journal of Cancer Research

影响因子:6.3

doi:10.3978/j.issn.1000-9604.2013.08.01

Ying, Min; He, Yingjian; Qi, Meng; Dong, Bin; Lu, Aiping; Li, Jinfeng; Xie, Yuntao; Wang, Tianfeng; Lin, Benyao; Ouyang, Tao

免疫/内分泌

发表日期：2013

文献求助收藏

Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer

ER-α36（一种新型雌激素受体α变体）的表达与乳腺癌中对三苯氧胺治疗的耐药性相关

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.2008.17.2254

Shi, Liang; Dong, Bin; Li, Zhongwu; Lu, Yunwei; Ouyang, Tao; Li, Jinfeng; Wang, Tianfeng; Fan, Zhaoqing; Fan, Tie; Lin, Benyao; Wang, Zhaoyi; Xie, Yuntao

免疫/内分泌

发表日期：2009

文献求助收藏